SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-010630
Filing Date
2018-02-23
Accepted
2018-02-23 17:22:05
Documents
5
Period of Report
2018-02-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv486939_8k.htm 8-K 22756
2 EXHIBIT 1.1 tv486939_ex1-1.htm EX-1.1 189704
3 EXHIBIT 5.1 tv486939_ex5-1.htm EX-5.1 9792
4 GRAPHIC ap_logo1.jpg GRAPHIC 16844
5 GRAPHIC ap_logo2.jpg GRAPHIC 8102
  Complete submission text file 0001144204-18-010630.txt   258137
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 18637745
SIC: 2836 Biological Products, (No Diagnostic Substances)